Novartis plans filing for Gilenya in paediatric MS
September 5, 2017PARADIGM study meets primary endpoint.
X
Novartis plans filing for Gilenya in paediatric MS
https://pharmaphorum.com/news/novartis-plans-filing-gilenya-paediatric-ms/
neurology
FDA names MDMA a ‘breakthrough’ for post-traumatic stress
August 29, 2017US non-profit organisation to begin late-stage trials this year
AZ to develop Parkinson’s drug with Takeda
August 29, 2017
GW prepares for 2018 US launch of epilepsy drug
August 8, 2017But Zynerba’s cannabis epilepsy drug fails in phase 2.
Alder shares slump despite migraine success
June 28, 2017Investors concerned over strong placebo effect
UK patients gain early access to Duchenne drug
June 26, 2017Patients to get Santhera’s Raxone under EAMS scheme.
Shire long-acting ADHD drug finally approved
June 21, 2017Mydadis approval ends decade-long saga with FDA.
Novartis files migraine drug with EMA
June 21, 2017Erenumab could be first new treatment in a decade.
